Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea.
Lee, Kyong Joo
Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea. [electronic resource] - Cancer chemotherapy and pharmacology Oct 2017 - 799-805 p. digital
Publication Type: Journal Article; Multicenter Study
1432-0843
10.1007/s00280-017-3421-7 doi
Adult
Aged
Aged, 80 and over
Anemia--chemically induced
Antineoplastic Agents--adverse effects
Disease-Free Survival
Everolimus--adverse effects
Exanthema--chemically induced
Female
Humans
Male
Middle Aged
Neoplasm Grading
Neoplasm Recurrence, Local
Pancreatic Neoplasms--drug therapy
Prognosis
Republic of Korea
Retrospective Studies
Stomatitis--chemically induced
Treatment Outcome
Young Adult
Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea. [electronic resource] - Cancer chemotherapy and pharmacology Oct 2017 - 799-805 p. digital
Publication Type: Journal Article; Multicenter Study
1432-0843
10.1007/s00280-017-3421-7 doi
Adult
Aged
Aged, 80 and over
Anemia--chemically induced
Antineoplastic Agents--adverse effects
Disease-Free Survival
Everolimus--adverse effects
Exanthema--chemically induced
Female
Humans
Male
Middle Aged
Neoplasm Grading
Neoplasm Recurrence, Local
Pancreatic Neoplasms--drug therapy
Prognosis
Republic of Korea
Retrospective Studies
Stomatitis--chemically induced
Treatment Outcome
Young Adult